CFTR and lung disorder: The robust response of MCT to the application of the CFTR potentiator ivacaftor, an agent with a high degree of selectivity for CFTR [17], further strengthens the argument that deficient CFTR activity has an important role governing delayed MCC in smoking-related lung diseases (Fig. 6).